Sheng-xiang Ren
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Author Correction: Targeting thymine DNA glycosylase induces synthetic lethality in p53-deficient cancers.
Journal: Nature chemical biology
Published: February 18, 2026
Targeting thymine DNA glycosylase induces synthetic lethality in p53-deficient cancers.
Journal: Nature chemical biology
Published: February 17, 2025
Expert Consensus Recommendations on Biomarker Testing in Metastatic and Nonmetastatic NSCLC in Asia.
Expert Consensus Recommendations on Biomarker Testing in Metastatic and Nonmetastatic NSCLC in Asia.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: March 02, 2022
A Novel Combined Conjugate Therapeutic Cancer Vaccine, Recombinant EGF-CRM197, in Patients With Advanced Solid Tumors: A Phase I Clinical Study.
Journal: Frontiers in oncology
Published: July 22, 2021
Genomic signatures define three subtypes of EGFR-mutant stage II-III non-small-cell lung cancer with distinct adjuvant therapy outcomes.
Journal: Nature communications
Published: April 24, 2021
Gefitinib Versus Vinorelbine Plus Cisplatin as Adjuvant Treatment for Stage II-IIIA (N1-N2) EGFR-Mutant NSCLC: Final Overall Survival Analysis of CTONG1104 Phase III Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: December 17, 2020
Frequency of the acquired resistant mutation T790 M in non-small cell lung cancer patients with active exon 19Del and exon 21 L858R: a systematic review and meta-analysis.
Journal: BMC cancer
Published: November 04, 2016
High feasibility of liquid-based cytological samples for detection of EGFR mutations in Chinese patients with NSCLC.
Journal: Asian Pacific journal of cancer prevention : APJCP
Published: October 09, 2014
Efficacy of first-line chemotherapy affects the second-line setting response in patients with advanced non-small cell lung cancer.
Journal: Asian Pacific journal of cancer prevention : APJCP
Published: August 30, 2014
Effect of Wnt signaling suppression on gefitinib in non small cell lung cancer cell lines
Journal: Zhonghua bing li xue za zhi = Chinese journal of pathology
Published: November 20, 2013
Serum cytokine levels in patients with advanced non-small cell lung cancer: correlation with clinical outcome of erlotinib treatment.
Journal: Chinese medical journal
Published: October 26, 2013
Last Updated: 09/26/2026